STERIS plc (STE)

Price$212.35

Value ScoreC

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-28.18%

Price vs S&P 500 (4W)2.37%

VGM Score56.54

Market Capitalization$20.73B

P/E Ratio (Annual)26.49x

Indicated Dividend Yield (Annual)1.19%

All Metrics

P/CF (Annual)15.45x

Book Value / Share (Quarterly)$73.45

P/TBV (Annual)3.90x

Indicated Dividend (Annual)$2.52

Revenue Growth (3Y)6.19%

Cash Flow / Share (Quarterly)$9.94

Payout Ratio (TTM)30.91%

Price vs S&P 500 (YTD)-24.40%

Gross Margin (TTM)44.25%

Net Profit Margin (TTM)13.18%

EPS (TTM)$7.94

10-Day Avg Trading Volume0.81M

EPS Excl Extra (TTM)$7.94

Revenue Growth (5Y)13.82%

EPS (Annual)$7.93

Dividend / Share (Annual)$2.47

ROI (Annual)8.58%

Gross Margin (Annual)44.25%

Net Profit Margin (5Y Avg)7.86%

Cash / Share (Quarterly)$4.49

P/E Basic Excl Extra (TTM)26.49x

Revenue Growth QoQ (YoY)7.29%

EPS Growth (5Y)11.37%

P/E Normalized (Annual)26.49x

ROA (Last FY)7.29%

Revenue Growth TTM (YoY)8.73%

EBITD / Share (TTM)$16.08

ROE (5Y Avg)6.34%

Operating Margin (TTM)18.50%

Cash Flow / Share (Annual)$9.94

P/B Ratio2.89x

P/B Ratio (Quarterly)3.02x

Net Income / Employee (Annual)$44,000

EV / Revenue (TTM)3.74x

Net Interest Coverage (TTM)21.58x

ROA (TTM)7.42%

EPS Growth QoQ (YoY)51.70%

EV / EBITDA (TTM)14.02x

EPS Incl Extra (Annual)$7.93

Current Ratio (Annual)2.09x

Quick Ratio (Quarterly)1.34x

3-Month Avg Trading Volume0.86M

52-Week Price Return-12.82%

EV / Free Cash Flow (Annual)22.85x

P/E Incl Extra (TTM)26.49x

Revenue / Employee (TTM)$333,700

Tangible BV / Share (Quarterly)$56.89

P/S Ratio (Annual)3.49x

Asset Turnover (Annual)0.55x

52-Week High$269.44

Operating Margin (5Y Avg)13.09%

EPS Excl Extra (Annual)$7.93

CapEx CAGR (5Y)9.05%

Tangible BV CAGR (5Y)13.28%

26-Week Price Return-20.25%

Quick Ratio (Annual)1.34x

13-Week Price Return-10.97%

Total Debt / Equity (Annual)0.27x

Current Ratio (Quarterly)2.09x

Enterprise Value$22.22B

Revenue / Share Growth (5Y)10.70%

Asset Turnover (TTM)0.56x

Book Value / Share Growth (5Y)9.98%

Revenue / Employee (Annual)$333,700

Inventory Turnover (Annual)5.46x

Pretax Margin (Annual)17.64%

Cash / Share (Annual)$4.49

3-Month Return Std Dev25.24%

Gross Margin (5Y Avg)43.79%

Net Income / Employee (TTM)$44,000

EBITDA CAGR (5Y)15.60%

EBITDA Interim CAGR (5Y)16.50%

ROE (Last FY)10.89%

Net Interest Coverage (Annual)21.58x

EPS Basic Excl Extra (Annual)$7.93

P/FCF (TTM)21.31x

Receivables Turnover (TTM)5.56x

EV / Free Cash Flow (TTM)22.85x

Total Debt / Equity (Quarterly)0.27x

EPS Incl Extra (TTM)$7.94

Receivables Turnover (Annual)5.56x

ROI (TTM)8.71%

Dividend Growth Rate (5Y)9.39%

P/S Ratio (TTM)3.49x

Pretax Margin (5Y Avg)11.19%

Revenue / Share (Annual)$60.14

Tangible BV / Share (Annual)$56.89

Forward P/E19.00x

Free OCF CAGR (5Y)16.65%

Price vs S&P 500 (52W)-37.19%

P/E Ratio (TTM)26.49x

EPS Growth TTM (YoY)27.95%

Year-to-Date Return-16.24%

5-Day Price Return0.61%

EPS Normalized (Annual)$7.93

ROA (5Y Avg)3.98%

Net Profit Margin (Annual)13.18%

Month-to-Date Return-0.18%

Cash Flow / Share (TTM)$11.21

EBITD / Share (Annual)$16.06

EPS Growth (3Y)95.06%

Operating Margin (Annual)18.50%

LT Debt / Equity (Annual)0.25x

P/CF (TTM)15.45x

ROI (5Y Avg)4.68%

P/E Excl Extra (TTM)26.49x

LT Debt / Equity (Quarterly)0.25x

EPS Basic Excl Extra (TTM)$7.94

P/TBV (Quarterly)3.90x

Payout Ratio (Annual)30.91%

P/B Ratio (Annual)3.02x

Dividend / Share (TTM)$2.47

Inventory Turnover (TTM)5.46x

Pretax Margin (TTM)17.64%

Book Value / Share (Annual)$73.45

Price vs S&P 500 (13W)-19.22%

Net Margin Growth (5Y)0.60%

Dividend Yield (TTM)1.17%

Beta0.92x

P/FCF (Annual)21.31x

Revenue / Share (TTM)$60.33

ROE (TTM)11.06%

52-Week Low$195.14

vGradeC

gGradeB

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q4 262.83est. 2.88

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

3.86

3.87

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
STESTERIS plc	C	B	C	$212.35
ISRGIntuitive Surgical Inc.	F	B	C	$422.06
EWEdwards Lifesciences Corp	D	C	C	$85.96
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$87.33
ALGNAlign Technology Inc	B	C	C	$167.74
SNNSmith & Nephew plc	B	C	C	$30.61
MSAMine Safety Incorporated	B	C	C	$161.30
ESTAEstablishment Labs Holdings Inc.	F	A	B	$74.31
ENOVEnovis Corporation	B	D	C	$23.78
CDRECadre Holdings, Inc.	C	C	D	$30.01
AVNSAvanos Medical, Inc.	B	D	A	$25.05

About

Steris is a global market leader in contract sterilization services for hospitals and medical device manufacturers, with additional revenue from sterilization equipment, washers, and decontamination solutions. The company derives approximately 70% of revenue from healthcare services, 19% from Applied Sterilization Technologies, and 11% from life sciences services, serving care providers and biopharma manufacturers.